share_log

We Ran A Stock Scan For Earnings Growth And Intuitive Surgical (NASDAQ:ISRG) Passed With Ease

We Ran A Stock Scan For Earnings Growth And Intuitive Surgical (NASDAQ:ISRG) Passed With Ease

我們進行了股票掃描以尋找收益增長,而直覺外科公司(納斯達克: ISRG)輕鬆通過了
Simply Wall St ·  10/03 18:03

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. A loss-making company is yet to prove itself with profit, and eventually the inflow of external capital may dry up.

對於一些投機者來說,投資一家能扭轉乾坤的公司的激動人心的是一個很大的吸引力,所以即使是沒有營業收入、沒有盈利,並且營業額不達標的公司也可以找到投資人。但現實情況是,當一家公司虧損多年後,其投資者通常會分擔其中的損失。一家虧損的公司尚未證明其能帶來利潤,並且外部資本的流入最終可能會枯竭。

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Intuitive Surgical (NASDAQ:ISRG). While profit isn't the sole metric that should be considered when investing, it's worth recognising businesses that can consistently produce it.

因此,如果這種高風險高回報的想法不適合您,您可能更感興趣的是像直覺外科公司(納斯達克:ISRG)這樣盈利增長的公司。儘管利潤不是投資時唯一應考慮的指標,但值得注意的是一些能夠持續產生利潤的企業。

Intuitive Surgical's Earnings Per Share Are Growing

直覺外科公司的每股收益正在增長

If you believe that markets are even vaguely efficient, then over the long term you'd expect a company's share price to follow its earnings per share (EPS) outcomes. That makes EPS growth an attractive quality for any company. We can see that in the last three years Intuitive Surgical grew its EPS by 8.7% per year. That growth rate is fairly good, assuming the company can keep it up.

如果您相信市場甚至稍微有效,那麼從長期來看,您預計公司的股價會遵循其每股收益(EPS)的結果。這使得EPS增長對於任何公司都是一種吸引人的品質。我們可以看到,在過去三年中,直覺外科公司的每股收益平均每年增長8.7%。假設公司能夠保持這種增長速度,那將是相當不錯的。

One way to double-check a company's growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. While we note Intuitive Surgical achieved similar EBIT margins to last year, revenue grew by a solid 14% to US$7.6b. That's a real positive.

檢查公司增長的一種方法是查看其營業收入和利息稅前利潤(EBIT)利潤率的變化。儘管我們注意到直覺外科公司的EBIT利潤率與去年相似,但營業收入增長了14%,達到76億美元。這是一個真正的積極因素。

In the chart below, you can see how the company has grown earnings and revenue, over time. For finer detail, click on the image.

在下面的圖表中,您可以看到公司的盈利和收入隨着時間的推移而增長。要獲得更精細的詳細信息,請單擊圖像。

big
NasdaqGS:ISRG Earnings and Revenue History October 3rd 2024
納斯達克納斯達克股票代碼:ISRG 直覺外科公司盈利和營業收入歷史數據2024年10月3日

Of course the knack is to find stocks that have their best days in the future, not in the past. You could base your opinion on past performance, of course, but you may also want to check this interactive graph of professional analyst EPS forecasts for Intuitive Surgical.

當然,訣竅在於找到那些未來業績輝煌的股票,而不是過去的。你可以基於過去的表現來形成觀點,但你也可能想要查看這個專業分析師EPS預測的互動圖表。

Are Intuitive Surgical Insiders Aligned With All Shareholders?

直覺外科公司內部人士是否與所有股東保持一致?

We would not expect to see insiders owning a large percentage of a US$172b company like Intuitive Surgical. But we do take comfort from the fact that they are investors in the company. We note that their impressive stake in the company is worth US$849m. While that is a lot of skin in the game, we note this holding only totals to 0.5% of the business, which is a result of the company being so large. This should still be a great incentive for management to maximise shareholder value.

我們不會期望看到內部人士擁有像直覺外科公司這樣的一家價值爲1720億美元的公司的大部分股份。但我們對他們是公司投資者的事實感到安慰。我們注意到他們在公司的令人印象深刻的股權價值爲84900萬美元。雖然這是巨額投資,但我們注意到這一持股僅佔業務的0.5%,這是因爲公司規模如此之大。這仍然應該是管理層最大限度地提高股東價值的動力。

Does Intuitive Surgical Deserve A Spot On Your Watchlist?

直覺外科公司是否值得加入你的自選股列表?

One positive for Intuitive Surgical is that it is growing EPS. That's nice to see. If that's not enough on its own, there is also the rather notable levels of insider ownership. The combination definitely favoured by investors so consider keeping the company on a watchlist. Still, you should learn about the 1 warning sign we've spotted with Intuitive Surgical.

對直覺外科公司的一個積極因素是其不斷增長的每股收益。這是一個好跡象。如果這本身還不夠的話,還有相當顯著的內部持股水平。這種組合絕對受到投資者青睞,因此考慮將公司保留在自選股列表中。不過,你應該了解我們發現的直覺外科公司的1個警示信號。

There's always the possibility of doing well buying stocks that are not growing earnings and do not have insiders buying shares. But for those who consider these important metrics, we encourage you to check out companies that do have those features. You can access a tailored list of companies which have demonstrated growth backed by significant insider holdings.

總是有可能買入未增長收益並且內部人員不買入股票的股票表現良好。但是對於那些認爲這些重要指數的人,我們鼓勵您查看具有這些功能的公司。您可以訪問定製列表,其中列出了已經展示出增長並得到內幕人員認可的公司。

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.

請注意,本文討論的內部交易是指在相關司法管轄區中報告的交易。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論